637 related articles for article (PubMed ID: 12001126)
1. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.
Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH
Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
3. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
4. Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis.
Kocher M; Maarouf M; Bendel M; Voges J; Müller RP; Sturm V
Strahlenther Onkol; 2004 May; 180(5):263-7. PubMed ID: 15127155
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery for patients with "radioresistant" brain metastases.
Brown PD; Brown CA; Pollock BE; Gorman DA; Foote RL
Neurosurgery; 2002 Sep; 51(3):656-65; discussion 665-7. PubMed ID: 12188943
[TBL] [Abstract][Full Text] [Related]
6. Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases.
Kong DS; Lee JI; Im YS; Nam DH; Park K; Kim JH
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):385-9. PubMed ID: 20097485
[TBL] [Abstract][Full Text] [Related]
7. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
[TBL] [Abstract][Full Text] [Related]
8. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
9. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
Knisely JP; Berkey B; Chakravarti A; Yung AW; Curran WJ; Robins HI; Movsas B; Brachman DG; Henderson RH; Mehta MP
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):79-86. PubMed ID: 18164847
[TBL] [Abstract][Full Text] [Related]
10. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
Selek U; Chang EL; Hassenbusch SJ; Shiu AS; Lang FF; Allen P; Weinberg J; Sawaya R; Maor MH
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1097-106. PubMed ID: 15234044
[TBL] [Abstract][Full Text] [Related]
12. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
13. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.
Rades D; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Nov; 110(10):2285-92. PubMed ID: 17922523
[TBL] [Abstract][Full Text] [Related]
14. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma.
Hara W; Tran P; Li G; Su Z; Puataweepong P; Adler JR; Soltys SG; Chang SD; Gibbs IC
Neurosurgery; 2009 Feb; 64(2 Suppl):A26-32. PubMed ID: 19165071
[TBL] [Abstract][Full Text] [Related]
15. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.
Rades D; Heisterkamp C; Huttenlocher S; Bohlen G; Dunst J; Haatanen T; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):537-41. PubMed ID: 19733017
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
17. RPA classification has prognostic significance for surgically resected single brain metastasis.
Tendulkar RD; Liu SW; Barnett GH; Vogelbaum MA; Toms SA; Jin T; Suh JH
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):810-7. PubMed ID: 17011454
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for brain metastases after whole brain radiotherapy. Data from a single institution.
Fleckenstein K; Hof H; Lohr F; Wenz F; Wannenmacher M
Strahlenther Onkol; 2004 May; 180(5):268-73. PubMed ID: 15127156
[TBL] [Abstract][Full Text] [Related]
19. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
[TBL] [Abstract][Full Text] [Related]
20. Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity.
Radbill AE; Fiveash JF; Falkenberg ET; Guthrie BL; Young PE; Meleth S; Markert JM
Cancer; 2004 Aug; 101(4):825-33. PubMed ID: 15305416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
